îæ€çŽ¢
îæ€çŽ¢
î
So-Young International Inc
SYîãŠã©ãããªã¹ãã«è¿œå
2.850USD
0.0000.00%
çµå€Â 05/15, 16:00ïŒETïŒ15åé
ãã®æ ªäŸ¡
285.85Mæ䟡ç·é¡
æ倱é¡çŽè¿12ã¶æPER
î
詳现æ å ± So-Young International Inc äŒæ¥å
So-Young International Inc is a holding company mainly engaged in online platform for discovering, evaluating and reserving medical aesthetic services. The Company operates its businesses through two segments including So-Young segment and Wuhan Miracle segment. So-Young segment mainly provides information services, reservation services, aesthetic treatment services and sales of medical products and maintenance services. Wuhan Miracle segment is mainly engaged in the research and development, production, sales and agency of laser and other optoelectronic medical equipment. The Company operates across multiple access points, including mobile app, Weixin mini program, and soyoung.com website.
So-Young International Incã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãSY
äŒç€ŸåSo-Young International Inc
äžå Žæ¥May 02, 2019
æé«çµå¶è²¬ä»»è
ãCEOãJin (Xing)
åŸæ¥å¡æ°1800
蚌åžçš®é¡Depository Receipt
決ç®ææ«May 02
æ¬ç€Ÿæåšå°2/F, East Tower, Poly Plaza, No. 66 Xiangbin Road, Chaoyang District
éœåžBEIJING
蚌åžååŒæNASDAQ OMX - NASDAQ BASIC
åœChina
éµäŸ¿çªå·100102
é»è©±çªå·861087902012
ãŠã§ããµã€ãhttps://www.soyoung.com/
äŒæ¥ã³ãŒãSY
äžå Žæ¥May 02, 2019
æé«çµå¶è²¬ä»»è
ãCEOãJin (Xing)
So-Young International Incã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Xing Jin
Mr. Xing Jin
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Haipeng Zhang, M.D.
Dr. Haipeng Zhang, M.D.
Independent Director
Independent Director
--
--
Prof. Chao He
Prof. Chao He
Independent Director
Independent Director
--
--
Mr. Xiaodong Ying
Mr. Xiaodong Ying
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Nan Huang
Mr. Nan Huang
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Hui Zhao
Mr. Hui Zhao
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
Ms. Nan Shen
Ms. Nan Shen
Independent Director
Independent Director
--
--
Ms. Mona Qiao
Ms. Mona Qiao
Investor Relations
Investor Relations
--
--
Ms. Bei Wang
Ms. Bei Wang
Chief Marketing Officer
Chief Marketing Officer
--
--
Ms. Gefei Li
Ms. Gefei Li
Chief Operating Officer
Chief Operating Officer
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Mr. Xing Jin
Mr. Xing Jin
Chairman of the Board, Chief Executive Officer, Co-Founder
Chairman of the Board, Chief Executive Officer, Co-Founder
--
--
Dr. Haipeng Zhang, M.D.
Dr. Haipeng Zhang, M.D.
Independent Director
Independent Director
--
--
Prof. Chao He
Prof. Chao He
Independent Director
Independent Director
--
--
Mr. Xiaodong Ying
Mr. Xiaodong Ying
Chief Technology Officer, Director
Chief Technology Officer, Director
--
--
Mr. Nan Huang
Mr. Nan Huang
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Hui Zhao
Mr. Hui Zhao
Chief Financial Officer, Director
Chief Financial Officer, Director
--
--
åçå èš³
é貚: USDæŽæ°æå»: Mon, Apr 6
é貚: USDæŽæ°æå»: Mon, Apr 6
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
äºæ¥å¥USD
äŒç€Ÿå
åç
æ¯ç
Information services and other
998.81M
79.40%
Sales of equipment and maintenance services
259.07M
20.60%
å°åå¥USD
äŒç€Ÿå
åç
æ¯ç
China (Mainland)
1.47B
0.00%
äºæ¥å¥
å°åå¥
äºæ¥å¥USD
äŒç€Ÿå
åç
æ¯ç
Information services and other
998.81M
79.40%
Sales of equipment and maintenance services
259.07M
20.60%
æ ªäž»
æŽæ°æå»: Thu, May 14
æŽæ°æå»: Thu, May 14
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Matrix Partners China
9.55%
TB Alternative Assets Ltd.
3.62%
Barclays Bank PLC
1.32%
Citi Investment Research (US)
1.22%
Kadensa Capital Limited
1.21%
ä»ã®
83.08%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
Matrix Partners China
9.55%
TB Alternative Assets Ltd.
3.62%
Barclays Bank PLC
1.32%
Citi Investment Research (US)
1.22%
Kadensa Capital Limited
1.21%
ä»ã®
83.08%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
Venture Capital
9.62%
Investment Advisor
6.01%
Research Firm
3.34%
Hedge Fund
1.98%
Corporation
1.11%
Investment Advisor/Hedge Fund
0.87%
ä»ã®
77.07%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Apr 1
æŽæ°æå»: Wed, Apr 1
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q1
64
18.48M
21.82%
-7.26M
2025Q4
60
18.01M
21.43%
-2.31M
2025Q3
50
16.48M
19.69%
+799.52K
2025Q2
56
5.46M
6.45%
+3.53M
2025Q1
56
39.98M
47.25%
+2.34M
2024Q4
57
35.00M
40.69%
-4.68M
2024Q3
62
35.08M
40.78%
-22.79M
2024Q2
68
35.66M
41.41%
-22.81M
2024Q1
74
35.91M
41.67%
-24.80M
2023Q4
80
36.94M
43.37%
-24.33M
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Matrix Partners China
8.09M
9.56%
-4.18M
-34.07%
Sep 30, 2025
TB Alternative Assets Ltd.
3.07M
3.63%
--
--
Dec 31, 2025
Barclays Bank PLC
1.12M
1.32%
+618.71K
+124.33%
Dec 31, 2025
Citi Investment Research (US)
1.04M
1.22%
+360.19K
+53.35%
Dec 31, 2025
Kadensa Capital Limited
1.02M
1.21%
--
--
Dec 31, 2025
Morgan Stanley & Co. LLC
899.76K
1.06%
-193.06K
-17.67%
Dec 31, 2025
Areo Holdings Ltd
709.77K
0.84%
--
--
Feb 28, 2025
State Street Investment Management (Japan)
462.50K
0.55%
+366.20K
+380.27%
Feb 28, 2026
Dimensional Fund Advisors, L.P.
179.41K
0.21%
+163.21K
+1007.36%
Dec 31, 2025
Beauty & Health Holdings Limited
233.07K
0.28%
+233.07K
--
Mar 31, 2025
詳现ãèŠã
é¢é£ETF
îæŽæ°æå»: Sat, Dec 6
æŽæ°æå»: Sat, Dec 6
éæå
æ¯ç
Invesco Golden Dragon China ETF
0.11%
SPDR S&P Emerging Markets Small Cap ETF
0.02%
Avantis Emerging Markets Small Cap Equity ETF
0.01%
SPDR S&P China ETF
0.01%
ActivePassive International Equity ETF
0%
Invesco Golden Dragon China ETF
æ¯ç0.11%
SPDR S&P Emerging Markets Small Cap ETF
æ¯ç0.02%
Avantis Emerging Markets Small Cap Equity ETF
æ¯ç0.01%
SPDR S&P China ETF
æ¯ç0.01%
ActivePassive International Equity ETF
æ¯ç0%
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
